Study Stopped
Poor enrollment
A Trial of Infant Flow Biphasic Nasal Continuous Airway Pressure (NCPAP) Versus Infant Flow NCPAP for the Facilitation of Extubation in Infants </= 1250 Grams
Infant Flow Biphasic NCPAP Versus Infant Flow NCPAP for the Facilitation of Successful Extubation in Infants </= 1250 Grams: A Randomized Controlled Trial
1 other identifier
interventional
136
1 country
1
Brief Summary
The purpose of this study is to compare two methods of delivering Nasal Continuous Airway Pressure (NCPAP): Biphasic Mode and a continuous mode, to see which is better in getting babies off the ventilator and decreasing lung damage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Apr 2006
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2006
CompletedFirst Posted
Study publicly available on registry
March 30, 2006
CompletedStudy Start
First participant enrolled
April 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedMay 5, 2009
May 1, 2009
2.7 years
March 28, 2006
May 4, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The rate of successful extubation with either mode of NCPAP
Day 7 post primary extubation
Secondary Outcomes (3)
The incidence of chronic lung disease
The incidence of other complications of prematurity including sepsis,retinopathy of prematurity, intraventricular haemorrhage/periventricular leucomalacia and necrotizing entercolitis
The predictive value of the minute ventilation test
Study Arms (2)
1
EXPERIMENTALBiphasic NCPAP
2
ACTIVE COMPARATORContinuous CPAP
Interventions
Eligibility Criteria
You may qualify if:
- Infants \</= 1250 grams who are going to be extubated
You may not qualify if:
- Congenital abnormalities of the upper airway
- Acquired nasal septum injury
- Congenital Heart Disease excluding Patent Ductus arteriosus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mount Sinai Hospital
Toronto, Ontario, M5G1X5, Canada
Related Publications (1)
O'Brien K, Campbell C, Brown L, Wenger L, Shah V. Infant flow biphasic nasal continuous positive airway pressure (BP- NCPAP) vs. infant flow NCPAP for the facilitation of extubation in infants' </= 1,250 grams: a randomized controlled trial. BMC Pediatr. 2012 Apr 4;12:43. doi: 10.1186/1471-2431-12-43.
PMID: 22475409DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karel O'Brien, MB, FRCPC
MOUNT SINAI HOSPITAL
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 28, 2006
First Posted
March 30, 2006
Study Start
April 1, 2006
Primary Completion
December 1, 2008
Study Completion
December 1, 2009
Last Updated
May 5, 2009
Record last verified: 2009-05